Core Viewpoint - Marex Group plc is set to release its fiscal 2025 first quarter results on May 15, 2025, before market open, indicating a commitment to transparency and investor engagement [1] Company Overview - Marex Group plc (NASDAQ:MRX) operates as a diversified global financial services platform, providing essential liquidity, market access, and infrastructure services across energy, commodities, and financial markets [2] - The company offers a comprehensive range of services, including Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions, with a strong presence in major metals, energy, and agricultural products [2] - Marex has access to 60 exchanges and serves a diverse client base, including large commodity producers, consumers, traders, banks, hedge funds, and asset managers [2] - The company employs over 2,400 staff across more than 40 offices worldwide, covering regions in Europe, Asia, and the Americas [2]

Core Insights - Bio-Techne Corporation has launched an Early Access Program for a new assay that enables high-resolution spatial visualization of protein interactions within complex tissues, enhancing the understanding of molecular signaling in disease processes [1][2] Group 1: New Assay Development - The new assay is based on Advanced Cell Diagnostics RNAscope™ technology and allows for in situ detection of protein proximity, providing a spatial solution for exploring functional interactions between proteins [1][2] - This technology addresses limitations of conventional methods that often lose spatial fidelity and do not provide localization data, thus offering a clear visual signal at subcellular resolution [2] Group 2: Research Applications - The assay is particularly valuable for research areas where context is crucial, such as immune checkpoint dynamics, bispecific antibodies, and protein interactions at synaptic junctions [2] - Proof-of-concept data and case studies will be presented at the 2025 American Association for Cancer Research (AACR) annual meeting, showcasing the assay's capabilities [3] Group 3: Company Overview - Bio-Techne Corporation is a global life sciences company that generated approximately $1.2 billion in net sales in fiscal 2024 and employs around 3,100 people worldwide [4]

Core Insights - Identiv, Inc. has announced a strategic partnership with Tag-N-Trac to enhance supply chain visibility for pharmaceutical companies through specialized IoT solutions focused on cold chain tracking [1][4] Company Overview - Identiv is a leader in RFID- and BLE-enabled IoT solutions, with its technology integrated into over 1.5 billion applications globally, driving innovation across various sectors including healthcare and consumer electronics [6] - Tag-N-Trac provides a full stack IoT platform for real-time supply chain visibility and traceability, focusing on solving complex supply chain and inventory management challenges [7] Partnership Details - The partnership combines Identiv's advanced BLE smart labels with Tag-N-Trac's RELATIVITY™ SaaS platform, which offers item-level visibility and actionable insights from origin to delivery [2] - The RELATIVITY platform enables real-time monitoring of ambient conditions such as temperature and humidity, ensuring compliance for temperature-sensitive products [2][3] Industry Context - The need for real-time data and visibility in the pharmaceutical cold chain is increasing due to growing regulatory requirements and patient safety concerns [3] - The collaboration aims to provide pharmaceutical companies with the necessary data intelligence to manage temperature-sensitive products safely and efficiently [4]

Core Viewpoint - EUDA Health Holdings Limited has shifted from a joint venture to a commercial distribution arrangement with Guangdong Cell Biotech, enhancing its access to advanced stem cell therapies and regenerative medicine in Southeast Asia [1][2][4]. Company Overview - EUDA Health Holdings Limited is a Singapore-based property management services provider and a leading non-invasive healthcare provider in Singapore and Malaysia, focusing on transforming the health and wellness landscape through innovative non-invasive treatments [5]. Strategic Partnership Update - The collaboration with Guangdong Cell Biotech will allow EUDA to market and sell stem cell therapies in Singapore and Malaysia through its subsidiary CK Health, which aligns with the company's mission to expand holistic healthcare access [3][4]. Business Strategy - The new commercial distribution structure is designed to diversify EUDA's business and revenue streams, combining its holistic healthcare solutions with Guangdong Cell Biotech's established therapies [5].

NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (NASDAQ:NDAQ) today reported financial results for the first quarter of 2025. First quarter 2025 net revenue1 was $1.2 billion, an increase of 11% over the first quarter of 2024, or up 12.5% on an adjusted2 basis. This included Solutions3 revenue growing 9%, or up 11% on an adjusted basis.Annualized Recurring Revenue (ARR)4 of $2.8 billion increased 8% over the first quarter of 2024, or up 9% on an organic basis. Annualized SaaS revenue increased 14% ...

SAN JOSE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ:PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended March 31, 2025. Recent Highlights Total revenue of $69.2 million for the first quarter of 2025, an increase of 55% compared to the prior year period in 2024U.S. handpiece and consumables revenue of 38.0 million for t ...

BEIJING, April 24, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that that it will change the ratio of its American Depositary Shares (the "ADSs") to its Class A ordinary shares (the "ADS Ratio"), par value US$0.01 per share, from the current ADS Ratio of one ADS to 200 Class A ordinary shares to a new ADS Ratio of one ADS to 800 Class A ordinary shares. The change in the ADS Ratio will become e ...

High Speed, Dedicated Connection to Azure Now Available from Digital Realty's Data CenterCampuses in Atlanta, Brussels, and Vienna DALLAS, April 24, 2025 /PRNewswire/ -- Digital Realty (NYSE: DLR), a global provider of cloud- and carrier-neutral data center, colocation, and interconnection solutions, today announced new Microsoft Azure ExpressRoute peering locations in Atlanta, Brussels, and Vienna, enabling customers to establish a dedicated connection from their private IT infrastructure to Azure services ...

COLUMBUS, Ohio, April 24, 2025 (GLOBE NEWSWIRE) -- Bread Financial® Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending, and saving solutions to millions of U.S. consumers, provided a performance update. The following tables present the Company’s net loss rate and delinquency rate for the periods indicated: For themonth endedMarch 31, 2025 For the three months endedMarch 31, 2025 (dollars in millions)End-of-period credit card and other ...

Continued strong financial results with record recurring monthly revenue and customer retention GAAP operating cash flows up 28%, Adjusted Free Cash Flow including interest rate swaps up 105% Returned $445 million to shareholders through share repurchases and dividends On track to achieve full year 2025 guidance metrics BOCA RATON, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) today reported results for the first quarter of 2025. Financial highlights for the first quarter are below with vari ...